Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 1
2018 1
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Rates of Actionable Genetic Findings in Individuals with Colorectal Cancer or Polyps Ascertained from a Community Medical Setting.
Gordon AS, Rosenthal EA, Carrell DS, Amendola LM, Dorschner MO, Scrol A, Stanaway IB, DeVange S, Ralston JD, Zouk H, Rehm HL, Larson E, Crosslin DR, Leppig KA, Jarvik GP. Gordon AS, et al. Am J Hum Genet. 2019 Sep 5;105(3):526-533. doi: 10.1016/j.ajhg.2019.07.012. Epub 2019 Aug 15. Am J Hum Genet. 2019. PMID: 31422818 Free PMC article.
We evaluated actionable genomic findings in community-based participants ascertained by three phenotypes: (1) CRC, (2) one or more adenomatous colon polyps, and (3) control participants over age 59 years without CRC or colon polyps. These …
We evaluated actionable genomic findings in community-based participants ascertained by three phenotypes: (1) CR …
Inherited DNA-Repair Defects in Colorectal Cancer.
AlDubayan SH, Giannakis M, Moore ND, Han GC, Reardon B, Hamada T, Mu XJ, Nishihara R, Qian Z, Liu L, Yurgelun MB, Syngal S, Garraway LA, Ogino S, Fuchs CS, Van Allen EM. AlDubayan SH, et al. Am J Hum Genet. 2018 Mar 1;102(3):401-414. doi: 10.1016/j.ajhg.2018.01.018. Epub 2018 Feb 22. Am J Hum Genet. 2018. PMID: 29478780 Free PMC article.
Colorectal cancer (CRC) heritability has been estimated to be around 30%. ...We evaluated the gene-level germline mutation enrichment of 40 DRGs in 680 unselected CRC individuals and 27,728 ancestry-matched cancer-free adults. Significant findings
Colorectal cancer (CRC) heritability has been estimated to be around 30%. ...We evaluated the gene-level germline mutation enr
Medically actionable pathogenic variants in a population of 13,131 healthy elderly individuals.
Lacaze P, Sebra R, Riaz M, Tiller J, Revote J, Phung J, Parker EJ, Orchard SG, Lockery JE, Wolfe R, Strahl M, Wang YC, Chen R, Sisco D, Arnold T, Thompson BA, Buchanan DD, Macrae FA, James PA, Abhayaratna WP, Lockett TJ, Gibbs P, Tonkin AM, Nelson MR, Reid CM, Woods RL, Murray AM, Winship I, McNeil JJ, Schadt E. Lacaze P, et al. Genet Med. 2020 Nov;22(11):1883-1886. doi: 10.1038/s41436-020-0881-7. Epub 2020 Jul 1. Genet Med. 2020. PMID: 32606442 Free PMC article.
PURPOSE: To measure the prevalence of medically actionable pathogenic variants (PVs) among a population of healthy elderly individuals. ...Participants had no previous diagnosis or current symptoms of cardiovascular disease, physical disability …
PURPOSE: To measure the prevalence of medically actionable pathogenic variants (PVs) among a population of healthy elderly …
Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes.
Frey MK, Sandler G, Sobolev R, Kim SH, Chambers R, Bassett RY, Martineau J, Sapra KJ, Boyd L, Curtin JP, Pothuri B, Blank SV. Frey MK, et al. Gynecol Oncol. 2017 Jul;146(1):123-128. doi: 10.1016/j.ygyno.2017.04.009. Epub 2017 May 8. Gynecol Oncol. 2017. PMID: 28495237
Clinical actionability for identified pathogenic mutations was characterized based on the National Comprehensive Cancer Network (NCCN) guidelines and consensus statements and expert opinion for genes not addressed by these guidelines. ...Three hundred and fifty-four …
Clinical actionability for identified pathogenic mutations was characterized based on the National Comprehensive Cancer Networ …
Panel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory.
Cragun D, Radford C, Dolinsky JS, Caldwell M, Chao E, Pal T. Cragun D, et al. Clin Genet. 2014 Dec;86(6):510-20. doi: 10.1111/cge.12359. Epub 2014 Mar 20. Clin Genet. 2014. PMID: 24506336 Free PMC article.
This study presents results from patients who underwent hereditary colorectal cancer (CRC) panel-based testing ('ColoNext() '). De-identified data from a clinical testing laboratory were used to calculate (1) frequencies for patient demographic, clinical, and family …
This study presents results from patients who underwent hereditary colorectal cancer (CRC) panel-based testing ('ColoNext() ') …
[New Classification for Advanced Colorectal Cancer Using CancerPlexGenomic Tests].
Kameyama H, Shimada Y, Ichikawa H, Nagahashi M, Sakata J, Kobayashi T, Nogami H, Maruyama S, Takii Y, Okuda S, Ling Y, Izutsu H, Kodama K, Nakada M, Wakai T. Kameyama H, et al. Gan To Kagaku Ryoho. 2016 Nov;43(11):1361-1365. Gan To Kagaku Ryoho. 2016. PMID: 27899776 Japanese.
Recently, targeted drugs have been developed for the treatment of colorectal cancer(CRC). Among targets, it is well known that KRAS mutations are associated with resistance to epidermal growth factor receptor(EGFR)monoclonal antibodies. ...Thus, because the RAS/MAP2 …
Recently, targeted drugs have been developed for the treatment of colorectal cancer(CRC). Among targets, it is well known that …
High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining.
Campton DE, Ramirez AB, Nordberg JJ, Drovetto N, Clein AC, Varshavskaya P, Friemel BH, Quarre S, Breman A, Dorschner M, Blau S, Blau CA, Sabath DE, Stilwell JL, Kaldjian EP. Campton DE, et al. BMC Cancer. 2015 May 6;15:360. doi: 10.1186/s12885-015-1383-x. BMC Cancer. 2015. PMID: 25944336 Free PMC article.
After staining, the slides were imaged using a digital scanning microscope (CyteFinder). Precisely counted model CTCs (mCTCs) from four cancer cell lines were spiked into whole blood to determine recovery rates. ...It thus enables accurate non-invasive monitoring of …
After staining, the slides were imaged using a digital scanning microscope (CyteFinder). Precisely counted model CTCs (mCTCs) from four c